Answers are grounded in this paper and cite their sources.
Cortical diffusivity metrics indicate neurodegeneration stages in genetic Parkinson's disease, suggesting potential biomarkers.
Cortical diffusivity metrics effectively capture cortical architectural changes across clinical stages of genetic PD, supporting their use as microstructural markers of neurodegeneration in PD.
No takes yet. Share an insight, caveat, or question.
Torso et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: